Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
28
Daily buy vs sell · 90 days
No data yet.
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| Uihlein Richard E | Director, 10% Owner | 62 | $40.79M | $0 | 2026-07-31 |
| Jamil Khurram | Chief Medical Officer | 52 | $0 | $1.45M | 2026-07-14 |
| Shlevin Harold H. | Director | 104 | $10.9K | $3.83M | 2026-06-29 |
| Brem Henry | Director | 1 | $0 | $0 | 2026-03-12 |
| ELDRED KARY | Director | 25 | $55.2K | $0 | 2026-02-06 |
| Zordani Richard A. Jr. | Director | 15 | $50.4K | $0 | 2026-01-16 |
| Schwartz Elissa J. | Director | 8 | $2.0K | $0 | 2026-01-16 |
| CARSON BENJAMIN SR | Director | 3 | $0 | $0 | 2026-01-16 |
| LEWIS JOEL | See Remarks | 148 | $79.5K | $759.8K | 2026-01-16 |
| FREEMAN KEVIN D | Director | 57 | $389.2K | $0 | 2026-01-16 |
| CALLICUTT JACK W | Chief Financial Officer | 109 | $21.5K | $4.00M | 2026-01-16 |
| OMENN GILBERT S | Director | 21 | $79.5K | $116.5K | 2026-01-16 |
| AMELIO GILBERT F | Director | 30 | $15.8K | $379.8K | 2026-01-16 |
| CZIRR JAMES C | Other | 142 | $2.54M | $9.10M | 2025-12-16 |
| 10X Capital Management, LLC | Other | 49 | $2.51M | $6.58M | 2025-12-03 |
| Rubin Marc | Director | 32 | $52.0K | $739.5K | 2025-01-23 |
| Boudes Pol F | Chief Medical Officer | 7 | $0 | $0 | 2024-01-24 |
| 10X Fund, L.P. | 10% Owner | 53 | $0 | $4.29M | 2022-07-27 |
| SHULMAN STEPHEN | Director | 2 | $0 | $0 | 2019-01-16 |
| TRABER PETER G | President and CEO | 25 | $77.3K | $1.16M | 2018-06-13 |
| ZUCCONI THEODORE DANIEL | Director | 8 | $2.3K | $15.5K | 2018-04-16 |
| MAULDIN JOHN F | Director | 18 | $54.5K | $0 | 2016-12-15 |
| Greenberg Arthur | Director | 8 | $38.2K | $0 | 2016-12-15 |
| Prelack Steven | Director | 25 | $0 | $71.0K | 2016-12-15 |
| PRESSLER HERMAN PAUL | Director | 6 | $15.5K | $0 | 2015-04-08 |
| Martin Rod D | Director | 39 | $12.2K | $2.81M | 2015-04-08 |
| MCGAULEY THOMAS | Chief Financial Officer | 3 | $23.5K | $0 | 2013-06-19 |
| ROME JERALD K | Director | 3 | $0 | $0 | 2013-03-28 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| Uihlein Richard E | Director, 10% Owner | M Exercise deriv | 2026-07-31 | 2026-08-04 | 0 | $10331275.00 | $0 | 0 | SEC↗ |
| Uihlein Richard E | Director, 10% Owner | M Exercise deriv | 2026-07-31 | 2026-08-04 | 0 | $95475705.00 | $0 | 0 | SEC↗ |
| Uihlein Richard E | Director, 10% Owner | M Exercise | 2026-07-31 | 2026-08-04 | 31,825,235 | $3.00 | $95.48M | 42,162,911 | SEC↗ |
| Uihlein Richard E | Director, 10% Owner | M Exercise | 2026-07-31 | 2026-08-04 | 2,550,932 | $4.05 | $10.33M | 44,713,843 | SEC↗ |
| Uihlein Richard E | Director, 10% Owner | M Exercise deriv | 2026-07-31 | 2026-08-04 | — | $10331275.00 | — | 0 | SEC↗ |
| Uihlein Richard E | Director, 10% Owner | M Exercise deriv | 2026-07-31 | 2026-08-04 | — | $95475705.00 | — | 0 | SEC↗ |
| Uihlein Richard E | Director, 10% Owner | M Exercise | 2026-07-31 | 2026-08-04 | 2,550,932 | $4.05 | $10.33M | 44,713,843 | SEC↗ |
| Uihlein Richard E | Director, 10% Owner | M Exercise | 2026-07-31 | 2026-08-04 | 31,825,235 | $3.00 | $95.48M | 42,162,911 | SEC↗ |
| Jamil Khurram | Chief Medical Officer | M Exercise deriv | 2026-07-14 | 2026-07-16 | 16,250 | — | $0 | 48,750 | SEC↗ |
| Jamil Khurram | Chief Medical Officer | M Exercise | 2026-07-14 | 2026-07-16 | 16,250 | $3.04 | $49.4K | 16,250 | SEC↗ |
| Jamil Khurram | Chief Medical Officer | S Sale | 2026-07-14 | 2026-07-16 | 16,250 | $5.13 | $83.4K | 0 | SEC↗ |
| Jamil Khurram | Chief Medical Officer | M Exercise deriv | 2026-06-29 | 2026-06-30 | 47,467 | — | $0 | 0 | SEC↗ |
| Shlevin Harold H. | Director | M Exercise deriv | 2026-06-29 | 2026-06-30 | 22,268 | — | $0 | 30,000 | SEC↗ |
| Jamil Khurram | Chief Medical Officer | M Exercise | 2026-06-29 | 2026-06-30 | 47,467 | $2.50 | $118.7K | 47,467 | SEC↗ |
| Jamil Khurram | Chief Medical Officer | S Sale | 2026-06-29 | 2026-06-30 | 47,467 | $5.04 | $239.2K | 0 | SEC↗ |
| Shlevin Harold H. | Director | M Exercise | 2026-06-29 | 2026-06-30 | 22,268 | $1.23 | $27.4K | 28,768 | SEC↗ |
| Shlevin Harold H. | Director | S Sale | 2026-06-29 | 2026-06-30 | 22,268 | $5.04 | $112.2K | 6,500 | SEC↗ |
| Jamil Khurram | Chief Medical Officer | M Exercise deriv | 2026-06-26 | 2026-06-30 | 2,037 | — | $0 | 100,000 | SEC↗ |
| Jamil Khurram | Chief Medical Officer | M Exercise deriv | 2026-06-26 | 2026-06-30 | 2,533 | — | $0 | 47,467 | SEC↗ |
| Shlevin Harold H. | Director | M Exercise deriv | 2026-06-26 | 2026-06-30 | 7,732 | — | $0 | 52,268 | SEC↗ |
| Jamil Khurram | Chief Medical Officer | M Exercise | 2026-06-26 | 2026-06-30 | 2,533 | $2.50 | $6.3K | 2,533 | SEC↗ |
| Jamil Khurram | Chief Medical Officer | S Sale | 2026-06-26 | 2026-06-30 | 2,533 | $5.00 | $12.7K | 0 | SEC↗ |
| Jamil Khurram | Chief Medical Officer | S Sale | 2026-06-26 | 2026-06-30 | 2,037 | $5.00 | $10.2K | 0 | SEC↗ |
| Jamil Khurram | Chief Medical Officer | M Exercise | 2026-06-26 | 2026-06-30 | 2,037 | $2.20 | $4.5K | 2,037 | SEC↗ |
| Shlevin Harold H. | Director | S Sale | 2026-06-26 | 2026-06-30 | 7,732 | $5.00 | $38.7K | 6,500 | SEC↗ |
| Shlevin Harold H. | Director | M Exercise | 2026-06-26 | 2026-06-30 | 7,732 | $1.23 | $9.5K | 14,232 | SEC↗ |
| Jamil Khurram | Chief Medical Officer | M Exercise deriv | 2026-06-23 | 2026-06-25 | 7,557 | — | $0 | 32,500 | SEC↗ |
| Jamil Khurram | Chief Medical Officer | S Sale | 2026-06-23 | 2026-06-25 | 7,557 | $3.14 | $23.7K | 0 | SEC↗ |
| Jamil Khurram | Chief Medical Officer | M Exercise | 2026-06-23 | 2026-06-25 | 7,557 | $1.23 | $9.3K | 7,557 | SEC↗ |
| Jamil Khurram | Chief Medical Officer | M Exercise deriv | 2026-05-26 | 2026-05-28 | 568 | — | $0 | 40,057 | SEC↗ |
| Jamil Khurram | Chief Medical Officer | M Exercise | 2026-05-26 | 2026-05-28 | 568 | $1.23 | $699 | 568 | SEC↗ |
| Jamil Khurram | Chief Medical Officer | S Sale | 2026-05-26 | 2026-05-28 | 568 | $3.10 | $1.8K | 0 | SEC↗ |
| Brem Henry | Director | A Award deriv | 2026-03-12 | 2026-03-17 | 60,000 | — | $0 | 60,000 | SEC↗ |
| ELDRED KARY | Director | P Buy | 2026-02-06 | 2026-02-09 | 300 | $2.70 | $810 | 65,682 | SEC↗ |
| Uihlein Richard E | Director, 10% Owner | A Award deriv | 2026-01-16 | 2026-01-21 | 60,000 | — | $0 | 60,000 | SEC↗ |
| Schwartz Elissa J. | Director | A Award deriv | 2026-01-16 | 2026-01-21 | 60,000 | — | $0 | 60,000 | SEC↗ |
| AMELIO GILBERT F | Director | A Award deriv | 2026-01-16 | 2026-01-21 | 60,000 | — | $0 | 60,000 | SEC↗ |
| OMENN GILBERT S | Director | A Award deriv | 2026-01-16 | 2026-01-21 | 60,000 | — | $0 | 60,000 | SEC↗ |
| Shlevin Harold H. | Director | A Award deriv | 2026-01-16 | 2026-01-21 | 60,000 | — | $0 | 60,000 | SEC↗ |
| CALLICUTT JACK W | Chief Financial Officer | A Award deriv | 2026-01-16 | 2026-01-21 | 65,000 | — | $0 | 65,000 | SEC↗ |
| CALLICUTT JACK W | Chief Financial Officer | A Award deriv | 2026-01-16 | 2026-01-21 | 100,000 | — | $0 | 100,000 | SEC↗ |
| LEWIS JOEL | President and CEO | A Award deriv | 2026-01-16 | 2026-01-21 | 120,000 | — | $0 | 100,000 | SEC↗ |
| LEWIS JOEL | President and CEO | A Award deriv | 2026-01-16 | 2026-01-21 | 84,000 | — | $0 | 65,000 | SEC↗ |
| ELDRED KARY | Director | A Award deriv | 2026-01-16 | 2026-01-21 | 60,000 | — | $0 | 60,000 | SEC↗ |
| FREEMAN KEVIN D | Director | A Award deriv | 2026-01-16 | 2026-01-21 | 60,000 | — | $0 | 60,000 | SEC↗ |
| Jamil Khurram | Chief Medical Officer | A Award deriv | 2026-01-16 | 2026-01-21 | 65,000 | — | $0 | 65,000 | SEC↗ |
| Jamil Khurram | Chief Medical Officer | A Award deriv | 2026-01-16 | 2026-01-21 | 100,000 | — | $0 | 100,000 | SEC↗ |
| Zordani Richard A. Jr. | Director | A Award deriv | 2026-01-16 | 2026-01-21 | 60,000 | — | $0 | 60,000 | SEC↗ |
| CARSON BENJAMIN SR | Director | A Award deriv | 2026-01-16 | 2026-01-21 | 60,000 | — | $0 | 60,000 | SEC↗ |
| LEWIS JOEL | President and CEO | A Award deriv | 2026-01-16 | 2026-01-22 | 91,000 | — | $0 | 91,000 | SEC↗ |
| Uihlein Richard E | Director, 10% Owner | A Award | 2026-01-16 | 2026-01-21 | 13,158 | $3.04 | $40.0K | 10,332,676 | SEC↗ |
| Jamil Khurram | Chief Medical Officer | S Sale | 2026-01-06 | 2026-01-06 | 21,446 | $3.65 | $78.3K | 0 | SEC↗ |
| CALLICUTT JACK W | Chief Financial Officer | S Sale | 2026-01-06 | 2026-01-06 | 20,354 | $3.67 | $74.7K | 7,614 | SEC↗ |
| LEWIS JOEL | President and CEO | S Sale | 2026-01-06 | 2026-01-06 | 37,698 | $3.58 | $135.0K | 832,592 | SEC↗ |
| Jamil Khurram | Chief Medical Officer | S Sale | 2026-01-05 | 2026-01-06 | 25,499 | $3.90 | $99.4K | 21,446 | SEC↗ |
| CALLICUTT JACK W | Chief Financial Officer | S Sale | 2026-01-05 | 2026-01-06 | 25,732 | $3.90 | $100.4K | 27,968 | SEC↗ |
| LEWIS JOEL | President and CEO | S Sale | 2026-01-05 | 2026-01-06 | 27,731 | $3.91 | $108.4K | 870,290 | SEC↗ |
| LEWIS JOEL | President and CEO | M Exercise deriv | 2026-01-02 | 2026-01-06 | 84,000 | — | $0 | 0 | SEC↗ |
| Jamil Khurram | Chief Medical Officer | M Exercise | 2026-01-02 | 2026-01-06 | 60,000 | — | $0 | 60,000 | SEC↗ |
| Jamil Khurram | Chief Medical Officer | S Sale | 2026-01-02 | 2026-01-06 | 13,055 | $4.20 | $54.8K | 46,945 | SEC↗ |
| CALLICUTT JACK W | Chief Financial Officer | S Sale | 2026-01-02 | 2026-01-06 | 13,914 | $4.20 | $58.4K | 53,700 | SEC↗ |
| CALLICUTT JACK W | Chief Financial Officer | M Exercise | 2026-01-02 | 2026-01-06 | 60,000 | — | $0 | 67,614 | SEC↗ |
| LEWIS JOEL | President and CEO | S Sale | 2026-01-02 | 2026-01-06 | 18,571 | $4.20 | $78.0K | 898,021 | SEC↗ |
| LEWIS JOEL | President and CEO | M Exercise | 2026-01-02 | 2026-01-06 | 84,000 | — | $0 | 916,592 | SEC↗ |
| Jamil Khurram | Chief Medical Officer | M Exercise deriv | 2026-01-01 | 2026-01-06 | 60,000 | — | $0 | 0 | SEC↗ |
| CALLICUTT JACK W | Chief Financial Officer | M Exercise deriv | 2026-01-01 | 2026-01-06 | 60,000 | — | $0 | 0 | SEC↗ |
| Jamil Khurram | Chief Medical Officer | M Exercise deriv | 2025-12-31 | 2026-01-05 | 8,125 | — | $0 | 40,625 | SEC↗ |
| Jamil Khurram | Chief Medical Officer | S Sale | 2025-12-31 | 2026-01-05 | 8,125 | $4.07 | $33.1K | 0 | SEC↗ |
| Jamil Khurram | Chief Medical Officer | M Exercise | 2025-12-31 | 2026-01-05 | 8,125 | $1.23 | $10.0K | 8,125 | SEC↗ |
| ELDRED KARY | Director | P Buy | 2025-12-23 | 2025-12-23 | 700 | $3.73 | $2.6K | 65,382 | SEC↗ |
| FREEMAN KEVIN D | Director | P Buy | 2025-12-23 | 2025-12-23 | 5,500 | $3.55 | $19.5K | 55,269 | SEC↗ |
| ELDRED KARY | Director | P Buy | 2025-12-23 | 2025-12-23 | 700 | $3.73 | $2.6K | 65,382 | SEC↗ |
| FREEMAN KEVIN D | Director | P Buy | 2025-12-23 | 2025-12-23 | 5,500 | $3.55 | $19.5K | 55,269 | SEC↗ |
| FREEMAN KEVIN D | Director | P Buy | 2025-12-23 | 2025-12-23 | 5,500 | $3.55 | $19.5K | 55,269 | SEC↗ |
| Shlevin Harold H. | Director | M Exercise deriv | 2025-12-17 | 2025-12-19 | 20,000 | — | $0 | 0 | SEC↗ |
| Jamil Khurram | Chief Medical Officer | M Exercise deriv | 2025-12-17 | 2025-12-19 | 6,463 | — | $0 | 102,037 | SEC↗ |
| Jamil Khurram | Chief Medical Officer | M Exercise deriv | 2025-12-17 | 2025-12-19 | 8,500 | — | $0 | 50,000 | SEC↗ |
| LEWIS JOEL | President and CEO | M Exercise deriv | 2025-12-17 | 2025-12-19 | 7,829 | — | $0 | 32,171 | SEC↗ |
| Shlevin Harold H. | Director | S Sale | 2025-12-17 | 2025-12-19 | 19,793 | $7.04 | $139.3K | 11,206 | SEC↗ |
| Shlevin Harold H. | Director | S Sale | 2025-12-17 | 2025-12-19 | 4,706 | $7.04 | $33.1K | 6,500 | SEC↗ |
| Shlevin Harold H. | Director | M Exercise | 2025-12-17 | 2025-12-19 | 20,000 | $1.98 | $39.6K | 31,206 | SEC↗ |
| Jamil Khurram | Chief Medical Officer | S Sale | 2025-12-17 | 2025-12-19 | 4,479 | $7.04 | $31.5K | 0 | SEC↗ |
| Jamil Khurram | Chief Medical Officer | S Sale | 2025-12-17 | 2025-12-19 | 6,463 | $7.04 | $45.5K | 0 | SEC↗ |
| Jamil Khurram | Chief Medical Officer | M Exercise | 2025-12-17 | 2025-12-19 | 8,500 | $2.50 | $21.3K | 8,500 | SEC↗ |
| Jamil Khurram | Chief Medical Officer | S Sale | 2025-12-17 | 2025-12-19 | 8,500 | $7.04 | $59.8K | 0 | SEC↗ |
| Jamil Khurram | Chief Medical Officer | M Exercise | 2025-12-17 | 2025-12-19 | 6,463 | $2.20 | $14.2K | 6,463 | SEC↗ |
| LEWIS JOEL | President and CEO | M Exercise | 2025-12-17 | 2025-12-19 | 7,829 | $2.86 | $22.4K | 840,421 | SEC↗ |
| LEWIS JOEL | President and CEO | S Sale | 2025-12-17 | 2025-12-19 | 7,829 | $7.06 | $55.3K | 832,592 | SEC↗ |
| CZIRR JAMES C | 10% Owner | S Sale | 2025-12-16 | 2025-12-18 | 30,681 | $6.66 | $204.3K | 5,614,457 | SEC↗ |
| Shlevin Harold H. | Director | M Exercise deriv | 2025-12-15 | 2025-12-16 | 8,417 | — | $0 | 0 | SEC↗ |
| Shlevin Harold H. | Director | S Sale | 2025-12-15 | 2025-12-16 | 8,417 | $6.30 | $53.0K | 11,206 | SEC↗ |
| Shlevin Harold H. | Director | M Exercise | 2025-12-15 | 2025-12-16 | 8,417 | $4.16 | $35.0K | 19,623 | SEC↗ |
| Shlevin Harold H. | Director | M Exercise deriv | 2025-12-12 | 2025-12-16 | 19,793 | — | $0 | 53,417 | SEC↗ |
| Shlevin Harold H. | Director | M Exercise | 2025-12-12 | 2025-12-16 | 19,793 | $4.16 | $82.3K | 30,999 | SEC↗ |
| Shlevin Harold H. | Director | S Sale | 2025-12-12 | 2025-12-16 | 19,793 | $6.27 | $124.1K | 11,206 | SEC↗ |
| Shlevin Harold H. | Director | M Exercise deriv | 2025-12-09 | 2025-12-10 | 16,790 | — | $0 | 73,210 | SEC↗ |
| Shlevin Harold H. | Director | S Sale | 2025-12-09 | 2025-12-10 | 16,790 | $6.27 | $105.3K | 11,206 | SEC↗ |
| Shlevin Harold H. | Director | M Exercise | 2025-12-09 | 2025-12-10 | 16,790 | $4.16 | $69.8K | 27,996 | SEC↗ |
| Shlevin Harold H. | Director | M Exercise deriv | 2025-12-08 | 2025-12-10 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Shlevin Harold H. | Director | M Exercise deriv | 2025-12-08 | 2025-12-10 | 20,000 | — | $0 | 20,000 | SEC↗ |
| Shlevin Harold H. | Director | M Exercise deriv | 2025-12-08 | 2025-12-10 | 35,000 | — | $0 | 35,000 | SEC↗ |
| Shlevin Harold H. | Director | M Exercise deriv | 2025-12-08 | 2025-12-10 | 20,000 | — | $0 | 20,000 | SEC↗ |
| Shlevin Harold H. | Director | M Exercise deriv | 2025-12-08 | 2025-12-10 | 20,000 | — | $0 | 20,000 | SEC↗ |
| Shlevin Harold H. | Director | M Exercise deriv | 2025-12-08 | 2025-12-10 | 35,000 | — | $0 | 35,000 | SEC↗ |
| Shlevin Harold H. | Director | S Sale | 2025-12-08 | 2025-12-10 | 20,000 | $6.00 | $120.0K | 11,206 | SEC↗ |
| Shlevin Harold H. | Director | M Exercise | 2025-12-08 | 2025-12-10 | 20,000 | $1.11 | $22.2K | 31,206 | SEC↗ |
| Shlevin Harold H. | Director | S Sale | 2025-12-08 | 2025-12-10 | 35,000 | $6.02 | $210.7K | 11,206 | SEC↗ |
| Shlevin Harold H. | Director | M Exercise | 2025-12-08 | 2025-12-10 | 35,000 | $2.11 | $73.8K | 46,206 | SEC↗ |
| Shlevin Harold H. | Director | S Sale | 2025-12-08 | 2025-12-10 | 25,000 | $5.95 | $148.8K | 11,206 | SEC↗ |
| Shlevin Harold H. | Director | M Exercise | 2025-12-08 | 2025-12-10 | 25,000 | $1.72 | $43.0K | 36,206 | SEC↗ |
| Shlevin Harold H. | Director | S Sale | 2025-12-08 | 2025-12-10 | 20,000 | $5.96 | $119.2K | 11,206 | SEC↗ |
| Shlevin Harold H. | Director | S Sale | 2025-12-08 | 2025-12-10 | 4,000 | $6.01 | $24.0K | 11,206 | SEC↗ |
| Shlevin Harold H. | Director | M Exercise | 2025-12-08 | 2025-12-10 | 35,000 | $2.86 | $100.1K | 46,206 | SEC↗ |
| Shlevin Harold H. | Director | S Sale | 2025-12-08 | 2025-12-10 | 35,000 | $5.95 | $208.3K | 11,206 | SEC↗ |
| Shlevin Harold H. | Director | M Exercise | 2025-12-08 | 2025-12-10 | 20,000 | $1.98 | $39.6K | 31,206 | SEC↗ |
| Shlevin Harold H. | Director | S Sale | 2025-12-08 | 2025-12-10 | 20,000 | $5.96 | $119.2K | 11,206 | SEC↗ |
| Shlevin Harold H. | Director | M Exercise | 2025-12-08 | 2025-12-10 | 20,000 | $2.11 | $42.2K | 31,206 | SEC↗ |
| 10X Capital Management, LLC | 10% Owner | S Sale | 2025-12-03 | 2025-12-04 | 120,000 | $5.73 | $687.6K | 5,682,207 | SEC↗ |
| 10X Capital Management, LLC | 10% Owner | S Sale | 2025-12-03 | 2025-12-08 | 132,069 | $5.73 | $756.8K | 5,670,138 | SEC↗ |
| 10X Capital Management, LLC | 10% Owner | S Sale | 2025-12-02 | 2025-12-04 | 30,000 | $5.47 | $164.1K | 5,802,207 | SEC↗ |
| 10X Capital Management, LLC | 10% Owner | S Sale | 2025-12-02 | 2025-12-08 | 30,000 | $5.47 | $164.1K | 5,802,207 | SEC↗ |
| CZIRR JAMES C | 10% Owner | J Other | 2025-11-24 | 2025-12-18 | 24,000 | — | $0 | 5,645,138 | SEC↗ |
| CALLICUTT JACK W | Chief Financial Officer | M Exercise deriv | 2025-11-18 | 2025-11-19 | 18,190 | — | $0 | 0 | SEC↗ |
| CALLICUTT JACK W | Chief Financial Officer | M Exercise deriv | 2025-11-18 | 2025-11-19 | 28,120 | — | $0 | 0 | SEC↗ |
| LEWIS JOEL | President and CEO | M Exercise deriv | 2025-11-18 | 2025-11-19 | 6,783 | — | $0 | 0 | SEC↗ |
| CALLICUTT JACK W | Chief Financial Officer | M Exercise | 2025-11-18 | 2025-11-19 | 18,210 | $1.11 | $20.2K | 25,824 | SEC↗ |
| CALLICUTT JACK W | Chief Financial Officer | S Sale | 2025-11-18 | 2025-11-19 | 28,100 | $6.22 | $174.8K | 7,614 | SEC↗ |
| CALLICUTT JACK W | Chief Financial Officer | M Exercise | 2025-11-18 | 2025-11-19 | 28,100 | $1.98 | $55.6K | 35,714 | SEC↗ |
| CALLICUTT JACK W | Chief Financial Officer | S Sale | 2025-11-18 | 2025-11-19 | 18,210 | $6.22 | $113.3K | 7,614 | SEC↗ |
| LEWIS JOEL | President and CEO | S Sale | 2025-11-18 | 2025-11-19 | 6,783 | $6.15 | $41.7K | 832,592 | SEC↗ |
| LEWIS JOEL | President and CEO | M Exercise | 2025-11-18 | 2025-11-19 | 6,783 | $2.39 | $16.2K | 839,375 | SEC↗ |
| CALLICUTT JACK W | Chief Financial Officer | M Exercise deriv | 2025-11-17 | 2025-11-19 | 9,586 | — | $0 | 28,120 | SEC↗ |
| CALLICUTT JACK W | Chief Financial Officer | M Exercise deriv | 2025-11-17 | 2025-11-19 | 19,701 | — | $0 | 18,190 | SEC↗ |
| CALLICUTT JACK W | Chief Financial Officer | M Exercise deriv | 2025-11-17 | 2025-11-19 | 2,323 | — | $0 | 48,750 | SEC↗ |
| LEWIS JOEL | President and CEO | M Exercise deriv | 2025-11-17 | 2025-11-19 | 15,680 | — | $0 | 6,783 | SEC↗ |
| CALLICUTT JACK W | Chief Financial Officer | S Sale | 2025-11-17 | 2025-11-19 | 2,323 | $6.03 | $14.0K | 7,614 | SEC↗ |
| CALLICUTT JACK W | Chief Financial Officer | M Exercise | 2025-11-17 | 2025-11-19 | 2,323 | $1.23 | $2.9K | 9,937 | SEC↗ |
| CALLICUTT JACK W | Chief Financial Officer | S Sale | 2025-11-17 | 2025-11-19 | 19,701 | $6.03 | $118.8K | 7,614 | SEC↗ |
| CALLICUTT JACK W | Chief Financial Officer | M Exercise | 2025-11-17 | 2025-11-19 | 19,701 | $1.11 | $21.9K | 27,315 | SEC↗ |
| CALLICUTT JACK W | Chief Financial Officer | S Sale | 2025-11-17 | 2025-11-19 | 9,586 | $6.03 | $57.8K | 7,614 | SEC↗ |
| CALLICUTT JACK W | Chief Financial Officer | M Exercise | 2025-11-17 | 2025-11-19 | 9,586 | $1.98 | $19.0K | 17,200 | SEC↗ |
| LEWIS JOEL | President and CEO | S Sale | 2025-11-17 | 2025-11-19 | 15,680 | $6.04 | $94.7K | 832,592 | SEC↗ |
| LEWIS JOEL | President and CEO | M Exercise | 2025-11-17 | 2025-11-19 | 15,680 | $2.39 | $37.5K | 848,272 | SEC↗ |
| Jamil Khurram | Chief Medical Officer | M Exercise deriv | 2025-11-13 | 2025-11-14 | 41,500 | — | $0 | 108,500 | SEC↗ |
| Jamil Khurram | Chief Medical Officer | M Exercise deriv | 2025-11-13 | 2025-11-14 | 16,250 | — | $0 | 48,750 | SEC↗ |
| Jamil Khurram | Chief Medical Officer | M Exercise deriv | 2025-11-13 | 2025-11-14 | 41,500 | — | $0 | 58,500 | SEC↗ |
| Jamil Khurram | Chief Medical Officer | M Exercise | 2025-11-13 | 2025-11-14 | 41,500 | $2.20 | $91.3K | 45,979 | SEC↗ |
| Jamil Khurram | Chief Medical Officer | S Sale | 2025-11-13 | 2025-11-14 | 16,250 | $5.47 | $88.9K | 4,479 | SEC↗ |
| Jamil Khurram | Chief Medical Officer | S Sale | 2025-11-13 | 2025-11-14 | 21,867 | $5.47 | $119.6K | 4,479 | SEC↗ |
| Jamil Khurram | Chief Medical Officer | S Sale | 2025-11-13 | 2025-11-14 | 41,500 | $5.47 | $227.0K | 4,479 | SEC↗ |
| Jamil Khurram | Chief Medical Officer | M Exercise | 2025-11-13 | 2025-11-14 | 16,250 | $1.23 | $20.0K | 20,729 | SEC↗ |
| Jamil Khurram | Chief Medical Officer | S Sale | 2025-11-13 | 2025-11-14 | 41,500 | $5.47 | $227.0K | 4,479 | SEC↗ |
| Jamil Khurram | Chief Medical Officer | M Exercise | 2025-11-13 | 2025-11-14 | 41,500 | $2.50 | $103.8K | 45,979 | SEC↗ |
| 10X Capital Management, LLC | 10% Owner | S Sale | 2025-11-11 | 2025-11-12 | 40,000 | $5.25 | $210.0K | 5,832,207 | SEC↗ |
| CALLICUTT JACK W | Chief Financial Officer | M Exercise deriv | 2025-11-10 | 2025-11-12 | 1,880 | — | $0 | 37,706 | SEC↗ |
| CALLICUTT JACK W | Chief Financial Officer | M Exercise deriv | 2025-11-10 | 2025-11-12 | 1,675 | — | $0 | 37,891 | SEC↗ |
| CALLICUTT JACK W | Chief Financial Officer | M Exercise deriv | 2025-11-10 | 2025-11-12 | 1,736 | — | $0 | 51,073 | SEC↗ |
| CALLICUTT JACK W | Chief Financial Officer | S Sale | 2025-11-10 | 2025-11-12 | 1,675 | $6.03 | $10.1K | 7,614 | SEC↗ |
| CALLICUTT JACK W | Chief Financial Officer | M Exercise | 2025-11-10 | 2025-11-12 | 1,880 | $1.98 | $3.7K | 9,694 | SEC↗ |
| CALLICUTT JACK W | Chief Financial Officer | M Exercise | 2025-11-10 | 2025-11-12 | 1,675 | $1.11 | $1.9K | 9,289 | SEC↗ |
| CALLICUTT JACK W | Chief Financial Officer | S Sale | 2025-11-10 | 2025-11-12 | 1,880 | $6.02 | $11.3K | 7,614 | SEC↗ |
| CALLICUTT JACK W | Chief Financial Officer | S Sale | 2025-11-10 | 2025-11-12 | 1,736 | $6.03 | $10.5K | 7,614 | SEC↗ |
| CALLICUTT JACK W | Chief Financial Officer | M Exercise | 2025-11-10 | 2025-11-12 | 1,736 | $1.23 | $2.1K | 9,350 | SEC↗ |
| LEWIS JOEL | President and CEO | S Sale | 2025-11-10 | 2025-11-12 | 1,867 | $6.03 | $11.3K | 832,592 | SEC↗ |
| LEWIS JOEL | President and CEO | M Exercise | 2025-11-10 | 2025-11-12 | 1,867 | $2.39 | $4.5K | 834,459 | SEC↗ |
| CALLICUTT JACK W | Chief Financial Officer | M Exercise deriv | 2025-11-05 | 2025-11-07 | 200 | — | $0 | 52,809 | SEC↗ |
| CALLICUTT JACK W | Chief Financial Officer | M Exercise deriv | 2025-11-05 | 2025-11-07 | 200 | — | $0 | 39,586 | SEC↗ |
| CALLICUTT JACK W | Chief Financial Officer | M Exercise deriv | 2025-11-05 | 2025-11-07 | 200 | — | $0 | 39,566 | SEC↗ |
| LEWIS JOEL | President and CEO | M Exercise deriv | 2025-11-05 | 2025-11-07 | 200 | — | $0 | 24,230 | SEC↗ |
| LEWIS JOEL | President and CEO | M Exercise deriv | 2025-11-05 | 2025-11-12 | 1,867 | — | $0 | 22,363 | SEC↗ |
| CALLICUTT JACK W | Chief Financial Officer | M Exercise | 2025-11-05 | 2025-11-07 | 200 | $1.72 | $344 | 7,814 | SEC↗ |
| CALLICUTT JACK W | Chief Financial Officer | S Sale | 2025-11-05 | 2025-11-07 | 200 | $6.00 | $1.2K | 7,614 | SEC↗ |
| CALLICUTT JACK W | Chief Financial Officer | M Exercise | 2025-11-05 | 2025-11-07 | 200 | $1.11 | $222 | 7,814 | SEC↗ |
| CALLICUTT JACK W | Chief Financial Officer | S Sale | 2025-11-05 | 2025-11-07 | 200 | $6.00 | $1.2K | 7,614 | SEC↗ |
| CALLICUTT JACK W | Chief Financial Officer | M Exercise | 2025-11-05 | 2025-11-07 | 200 | $1.98 | $396 | 7,814 | SEC↗ |
| CALLICUTT JACK W | Chief Financial Officer | S Sale | 2025-11-05 | 2025-11-07 | 200 | $6.00 | $1.2K | 7,614 | SEC↗ |
| LEWIS JOEL | President and CEO | M Exercise | 2025-11-05 | 2025-11-07 | 200 | $2.39 | $478 | 832,792 | SEC↗ |
| LEWIS JOEL | President and CEO | S Sale | 2025-11-05 | 2025-11-07 | 200 | $6.00 | $1.2K | 832,592 | SEC↗ |
| CALLICUTT JACK W | Chief Financial Officer | M Exercise deriv | 2025-11-04 | 2025-11-05 | 10,741 | — | $0 | 53,009 | SEC↗ |
| CALLICUTT JACK W | Chief Financial Officer | M Exercise deriv | 2025-11-04 | 2025-11-05 | 8,974 | — | $0 | 39,766 | SEC↗ |
| CALLICUTT JACK W | Chief Financial Officer | M Exercise deriv | 2025-11-04 | 2025-11-05 | 8,914 | — | $0 | 39,786 | SEC↗ |
| LEWIS JOEL | President and CEO | M Exercise deriv | 2025-11-04 | 2025-11-05 | 14,420 | — | $0 | 24,530 | SEC↗ |
| CALLICUTT JACK W | Chief Financial Officer | M Exercise | 2025-11-04 | 2025-11-05 | 8,914 | $1.98 | $17.6K | 16,528 | SEC↗ |
| CALLICUTT JACK W | Chief Financial Officer | S Sale | 2025-11-04 | 2025-11-05 | 8,914 | $6.07 | $54.1K | 7,614 | SEC↗ |
| CALLICUTT JACK W | Chief Financial Officer | M Exercise | 2025-11-04 | 2025-11-05 | 8,974 | $1.11 | $10.0K | 16,588 | SEC↗ |
| CALLICUTT JACK W | Chief Financial Officer | S Sale | 2025-11-04 | 2025-11-05 | 8,974 | $6.07 | $54.5K | 7,614 | SEC↗ |
| CALLICUTT JACK W | Chief Financial Officer | M Exercise | 2025-11-04 | 2025-11-05 | 10,741 | $1.72 | $18.5K | 18,355 | SEC↗ |
| CALLICUTT JACK W | Chief Financial Officer | S Sale | 2025-11-04 | 2025-11-05 | 10,741 | $6.07 | $65.2K | 7,614 | SEC↗ |
| LEWIS JOEL | President and CEO | S Sale | 2025-11-04 | 2025-11-05 | 14,420 | $6.07 | $87.5K | 832,592 | SEC↗ |
| LEWIS JOEL | President and CEO | M Exercise | 2025-11-04 | 2025-11-05 | 14,420 | $2.39 | $34.5K | 847,012 | SEC↗ |
| CALLICUTT JACK W | Chief Financial Officer | M Exercise deriv | 2025-11-03 | 2025-11-05 | 1,250 | — | $0 | 63,750 | SEC↗ |
| CALLICUTT JACK W | Chief Financial Officer | M Exercise deriv | 2025-11-03 | 2025-11-05 | 1,260 | — | $0 | 48,740 | SEC↗ |
| CALLICUTT JACK W | Chief Financial Officer | M Exercise deriv | 2025-11-03 | 2025-11-05 | 1,300 | — | $0 | 48,700 | SEC↗ |
| LEWIS JOEL | President and CEO | M Exercise deriv | 2025-11-03 | 2025-11-05 | 1,300 | — | $0 | 38,950 | SEC↗ |
| CALLICUTT JACK W | Chief Financial Officer | M Exercise | 2025-11-03 | 2025-11-05 | 1,260 | $1.11 | $1.4K | 8,874 | SEC↗ |
| CALLICUTT JACK W | Chief Financial Officer | S Sale | 2025-11-03 | 2025-11-05 | 1,300 | $6.01 | $7.8K | 7,614 | SEC↗ |
| CALLICUTT JACK W | Chief Financial Officer | S Sale | 2025-11-03 | 2025-11-05 | 1,260 | $6.01 | $7.6K | 7,614 | SEC↗ |
| CALLICUTT JACK W | Chief Financial Officer | M Exercise | 2025-11-03 | 2025-11-05 | 1,250 | $1.72 | $2.1K | 8,864 | SEC↗ |
| CALLICUTT JACK W | Chief Financial Officer | S Sale | 2025-11-03 | 2025-11-05 | 1,250 | $6.01 | $7.5K | 7,614 | SEC↗ |
| CALLICUTT JACK W | Chief Financial Officer | M Exercise | 2025-11-03 | 2025-11-05 | 1,300 | $1.98 | $2.6K | 8,914 | SEC↗ |
| LEWIS JOEL | President and CEO | S Sale | 2025-11-03 | 2025-11-05 | 1,300 | $6.01 | $7.8K | 832,592 | SEC↗ |
| LEWIS JOEL | President and CEO | M Exercise | 2025-11-03 | 2025-11-05 | 1,300 | $2.39 | $3.1K | 833,892 | SEC↗ |
| 10X Capital Management, LLC | 10% Owner | S Sale | 2025-10-22 | 2025-10-24 | 20,000 | $4.93 | $98.6K | 5,902,207 | SEC↗ |
| 10X Capital Management, LLC | 10% Owner | S Sale | 2025-10-22 | 2025-10-24 | 30,000 | $4.94 | $148.2K | 5,872,207 | SEC↗ |
| LEWIS JOEL | President and CEO | M Exercise deriv | 2025-09-12 | 2025-09-15 | 14,000 | $2.39 | $33.5K | 40,250 | SEC↗ |
| CALLICUTT JACK W | Chief Financial Officer | M Exercise deriv | 2025-09-12 | 2025-09-15 | 8,706 | $1.37 | $11.9K | 0 | SEC↗ |
| LEWIS JOEL | President and CEO | M Exercise | 2025-09-12 | 2025-09-15 | 14,000 | $2.39 | $33.5K | 846,592 | SEC↗ |
| LEWIS JOEL | President and CEO | S Sale | 2025-09-12 | 2025-09-15 | 14,000 | $6.36 | $89.0K | 832,592 | SEC↗ |
| CALLICUTT JACK W | Chief Financial Officer | S Sale | 2025-09-12 | 2025-09-15 | 8,706 | $6.44 | $56.1K | 7,614 | SEC↗ |
| CALLICUTT JACK W | Chief Financial Officer | M Exercise | 2025-09-12 | 2025-09-15 | 8,706 | $1.37 | $11.9K | 16,320 | SEC↗ |
| ELDRED KARY | Director | P Buy | 2025-07-21 | 2025-07-22 | 1,000 | $2.93 | $2.9K | 64,682 | SEC↗ |
| FREEMAN KEVIN D | Director | P Buy | 2025-07-17 | 2025-07-18 | 5,000 | $2.90 | $14.5K | 49,769 | SEC↗ |
| CZIRR JAMES C | 10% Owner | M Exercise deriv | 2025-06-06 | 2025-06-11 | 40,000 | — | $0 | 40,000 | SEC↗ |
| CZIRR JAMES C | 10% Owner | M Exercise deriv | 2025-06-06 | 2025-06-11 | 31,250 | — | $0 | 291,875 | SEC↗ |
| CZIRR JAMES C | 10% Owner | M Exercise deriv | 2025-06-06 | 2025-06-11 | 46,875 | — | $0 | 245,000 | SEC↗ |
| CZIRR JAMES C | 10% Owner | M Exercise deriv | 2025-06-06 | 2025-06-11 | 25,000 | — | $0 | 220,000 | SEC↗ |
| CZIRR JAMES C | 10% Owner | M Exercise deriv | 2025-06-06 | 2025-06-11 | 30,000 | — | $0 | 190,000 | SEC↗ |
| CZIRR JAMES C | 10% Owner | M Exercise deriv | 2025-06-06 | 2025-06-11 | 40,000 | — | $0 | 150,000 | SEC↗ |
| CZIRR JAMES C | 10% Owner | M Exercise deriv | 2025-06-06 | 2025-06-11 | 70,000 | — | $0 | 80,000 | SEC↗ |
| CZIRR JAMES C | 10% Owner | M Exercise deriv | 2025-06-06 | 2025-06-11 | 40,000 | — | $0 | 0 | SEC↗ |
| CZIRR JAMES C | 10% Owner | M Exercise | 2025-06-06 | 2025-06-11 | 70,000 | $2.11 | $147.7K | 965,541 | SEC↗ |
| CZIRR JAMES C | 10% Owner | M Exercise | 2025-06-06 | 2025-06-11 | 40,000 | $2.11 | $84.4K | 895,541 | SEC↗ |
| CZIRR JAMES C | 10% Owner | M Exercise | 2025-06-06 | 2025-06-11 | 30,000 | $2.86 | $85.8K | 855,541 | SEC↗ |
| CZIRR JAMES C | 10% Owner | M Exercise | 2025-06-06 | 2025-06-11 | 25,000 | $4.72 | $118.0K | 825,541 | SEC↗ |
| CZIRR JAMES C | 10% Owner | M Exercise | 2025-06-06 | 2025-06-11 | 40,000 | $1.11 | $44.4K | 1,045,541 | SEC↗ |
| CZIRR JAMES C | 10% Owner | M Exercise | 2025-06-06 | 2025-06-11 | 31,250 | $0.89 | $27.8K | 753,666 | SEC↗ |
| CZIRR JAMES C | 10% Owner | M Exercise | 2025-06-06 | 2025-06-11 | 40,000 | $1.98 | $79.2K | 1,005,541 | SEC↗ |
| CZIRR JAMES C | 10% Owner | M Exercise | 2025-06-06 | 2025-06-11 | 46,875 | $2.39 | $112.0K | 800,541 | SEC↗ |
| CZIRR JAMES C | 10% Owner | J Other | 2025-03-31 | 2025-06-11 | 1,000 | $6.00 | $6.0K | 722,416 | SEC↗ |
| LEWIS JOEL | President and CEO | A Award | 2025-03-03 | 2025-03-05 | 56,420 | $1.57 | $88.6K | 832,592 | SEC↗ |
| CZIRR JAMES C | 10% Owner | G Gift | 2025-02-04 | 2025-06-11 | 10,000 | — | $0 | 721,416 | SEC↗ |
| CZIRR JAMES C | 10% Owner | G Gift | 2025-02-03 | 2025-06-11 | 10,000 | — | $0 | 731,416 | SEC↗ |
| OMENN GILBERT S | Director | A Award deriv | 2025-01-23 | 2025-01-27 | 60,000 | — | $0 | 60,000 | SEC↗ |
| CALLICUTT JACK W | Chief Financial Officer | A Award deriv | 2025-01-23 | 2025-01-27 | 60,000 | — | $0 | 60,000 | SEC↗ |
| CALLICUTT JACK W | Chief Financial Officer | A Award deriv | 2025-01-23 | 2025-01-27 | 65,000 | — | $0 | 65,000 | SEC↗ |
| CARSON BENJAMIN SR | Director | A Award deriv | 2025-01-23 | 2025-01-27 | 60,000 | — | $0 | 60,000 | SEC↗ |
| ELDRED KARY | Director | A Award deriv | 2025-01-23 | 2025-01-27 | 60,000 | — | $0 | 60,000 | SEC↗ |
| FREEMAN KEVIN D | Director | A Award deriv | 2025-01-23 | 2025-01-27 | 60,000 | — | $0 | 60,000 | SEC↗ |
| Jamil Khurram | Chief Medical Officer | A Award deriv | 2025-01-23 | 2025-01-27 | 65,000 | — | $0 | 65,000 | SEC↗ |
| Jamil Khurram | Chief Medical Officer | A Award deriv | 2025-01-23 | 2025-01-27 | 60,000 | — | $0 | 60,000 | SEC↗ |
| LEWIS JOEL | President and CEO | A Award deriv | 2025-01-23 | 2025-01-27 | 84,000 | — | $0 | 84,000 | SEC↗ |
| LEWIS JOEL | President and CEO | A Award deriv | 2025-01-23 | 2025-01-27 | 91,000 | — | $0 | 91,000 | SEC↗ |
| OMENN GILBERT S | Director | A Award deriv | 2025-01-23 | 2025-01-27 | 60,000 | — | $0 | 60,000 | SEC↗ |
| Rubin Marc | Director | A Award deriv | 2025-01-23 | 2025-01-27 | 60,000 | — | $0 | 60,000 | SEC↗ |
| Schwartz Elissa J. | Director | A Award deriv | 2025-01-23 | 2025-01-27 | 60,000 | — | $0 | 60,000 | SEC↗ |
| Uihlein Richard E | Director, 10% Owner | A Award deriv | 2025-01-23 | 2025-01-27 | 60,000 | — | $0 | 60,000 | SEC↗ |
| Zordani Richard A. Jr. | Director | A Award deriv | 2025-01-23 | 2025-01-27 | 60,000 | — | $0 | 60,000 | SEC↗ |
| Shlevin Harold H. | Director | A Award deriv | 2025-01-23 | 2025-01-30 | 60,000 | — | $0 | 60,000 | SEC↗ |
| Uihlein Richard E | Director, 10% Owner | A Award | 2025-01-23 | 2025-01-27 | 32,520 | $1.23 | $40.0K | 10,301,271 | SEC↗ |
| Shlevin Harold H. | Director | P Buy | 2024-12-30 | 2024-12-31 | 6,500 | $1.16 | $7.5K | 15,206 | SEC↗ |
| FREEMAN KEVIN D | Director | P Buy | 2024-12-24 | 2024-12-26 | 10,000 | $0.81 | $8.1K | 44,769 | SEC↗ |
| ELDRED KARY | Director | P Buy | 2024-12-24 | 2024-12-26 | 13,469 | $0.82 | $11.0K | 63,682 | SEC↗ |
| Zordani Richard A. Jr. | Director | P Buy | 2024-12-24 | 2024-12-26 | 10,000 | $0.82 | $8.2K | 42,083 | SEC↗ |
| CALLICUTT JACK W | Chief Financial Officer | M Exercise deriv | 2024-12-23 | 2024-12-26 | 40,000 | — | $0 | 0 | SEC↗ |
| LEWIS JOEL | President and CEO | M Exercise deriv | 2024-12-23 | 2024-12-26 | 56,000 | — | $0 | 0 | SEC↗ |
| Jamil Khurram | Chief Medical Officer | M Exercise deriv | 2024-12-23 | 2024-12-26 | 40,000 | — | $0 | 0 | SEC↗ |
| CALLICUTT JACK W | Chief Financial Officer | S Sale | 2024-12-23 | 2024-12-26 | 40,000 | $0.89 | $35.6K | 7,614 | SEC↗ |
| CALLICUTT JACK W | Chief Financial Officer | M Exercise | 2024-12-23 | 2024-12-26 | 40,000 | — | $0 | 47,614 | SEC↗ |
| LEWIS JOEL | President and CEO | M Exercise | 2024-12-23 | 2024-12-26 | 56,000 | — | $0 | 953,012 | SEC↗ |
| LEWIS JOEL | President and CEO | S Sale | 2024-12-23 | 2024-12-26 | 56,000 | $0.89 | $49.8K | 897,012 | SEC↗ |
| Jamil Khurram | Chief Medical Officer | S Sale | 2024-12-23 | 2024-12-26 | 13,654 | $0.88 | $12.0K | 26,346 | SEC↗ |
| Jamil Khurram | Chief Medical Officer | M Exercise | 2024-12-23 | 2024-12-26 | 40,000 | — | $0 | 40,000 | SEC↗ |
| ELDRED KARY | Director | P Buy | 2024-10-23 | 2024-10-23 | 500 | $2.60 | $1.3K | 50,213 | SEC↗ |
| FREEMAN KEVIN D | Director | P Buy | 2024-10-17 | 2024-10-17 | 1,300 | $2.64 | $3.4K | 34,769 | SEC↗ |
| FREEMAN KEVIN D | Director | P Buy | 2024-10-16 | 2024-10-16 | 5,000 | $2.70 | $13.5K | 80,000 | SEC↗ |
| FREEMAN KEVIN D | Director | P Buy | 2024-10-16 | 2024-10-16 | 5,000 | $2.70 | $13.5K | 33,469 | SEC↗ |
| Zordani Richard A. Jr. | Director | P Buy | 2024-08-23 | 2024-08-26 | 1,759 | $2.30 | $4.0K | 32,083 | SEC↗ |
| Zordani Richard A. Jr. | Director | P Buy | 2024-08-23 | 2024-08-26 | 1,000 | $2.30 | $2.3K | 2,000 | SEC↗ |
| Zordani Richard A. Jr. | Director | P Buy | 2024-08-22 | 2024-08-26 | 741 | $2.30 | $1.7K | 30,324 | SEC↗ |
| Jamil Khurram | Chief Medical Officer | A Award deriv | 2024-08-01 | 2024-08-05 | 10,000 | — | $0 | 10,000 | SEC↗ |
| Jamil Khurram | Chief Medical Officer | A Award deriv | 2024-08-01 | 2024-08-05 | 100,000 | — | $0 | 100,000 | SEC↗ |
| ELDRED KARY | Director | P Buy | 2024-07-22 | 2024-07-23 | 400 | $2.39 | $956 | 49,713 | SEC↗ |
| FREEMAN KEVIN D | Director | P Buy | 2024-06-20 | 2024-06-20 | 2,500 | $2.38 | $6.0K | 28,469 | SEC↗ |
| Zordani Richard A. Jr. | Director | P Buy | 2024-04-30 | 2024-04-30 | 1,000 | $3.52 | $3.5K | 1,000 | SEC↗ |
| LEWIS JOEL | President and CEO | P Buy | 2024-04-24 | 2024-04-25 | 1,000 | $3.39 | $3.4K | 2,000 | SEC↗ |
| CZIRR JAMES C | 10% Owner | S Sale | 2024-04-23 | 2024-04-25 | 3,677 | $3.06 | $11.3K | 5,922,207 | SEC↗ |
| FREEMAN KEVIN D | Director | P Buy | 2024-04-22 | 2024-04-22 | 2,500 | $2.98 | $7.5K | 25,969 | SEC↗ |
| CZIRR JAMES C | 10% Owner | S Sale | 2024-04-22 | 2024-04-25 | 21,323 | $3.06 | $65.2K | 5,925,884 | SEC↗ |
| FREEMAN KEVIN D | Director | W Will | 2024-04-09 | 2024-04-09 | 2,063 | — | $0 | 18,063 | SEC↗ |
| LEWIS JOEL | President and CEO | A Award | 2024-03-01 | 2024-03-04 | 152,584 | $1.96 | $299.1K | 897,716 | SEC↗ |
| AMELIO GILBERT F | Director | A Award deriv | 2024-01-24 | 2024-02-07 | 50,000 | — | $0 | 50,000 | SEC↗ |
| Boudes Pol F | Chief Medical Officer | A Award deriv | 2024-01-24 | 2024-02-07 | 65,000 | — | $0 | 65,000 | SEC↗ |
| Boudes Pol F | Chief Medical Officer | A Award deriv | 2024-01-24 | 2024-02-07 | 40,000 | — | $0 | 40,000 | SEC↗ |
| CALLICUTT JACK W | Chief Financial Officer | A Award deriv | 2024-01-24 | 2024-02-07 | 40,000 | — | $0 | 40,000 | SEC↗ |
| CALLICUTT JACK W | Chief Financial Officer | A Award deriv | 2024-01-24 | 2024-02-07 | 65,000 | — | $0 | 65,000 | SEC↗ |
| CARSON BENJAMIN SR | Director | A Award deriv | 2024-01-24 | 2024-02-07 | 50,000 | — | $0 | 50,000 | SEC↗ |
| ELDRED KARY | Director | A Award deriv | 2024-01-24 | 2024-02-07 | 50,000 | — | $0 | 50,000 | SEC↗ |
| FREEMAN KEVIN D | Director | A Award deriv | 2024-01-24 | 2024-02-07 | 50,000 | — | $0 | 50,000 | SEC↗ |
| LEWIS JOEL | President and CEO | A Award deriv | 2024-01-24 | 2024-02-07 | 56,000 | — | $0 | 56,000 | SEC↗ |
| LEWIS JOEL | President and CEO | A Award deriv | 2024-01-24 | 2024-02-07 | 91,000 | — | $0 | 91,000 | SEC↗ |
| OMENN GILBERT S | Director | A Award deriv | 2024-01-24 | 2024-02-07 | 50,000 | — | $0 | 50,000 | SEC↗ |
| Rubin Marc | Director | A Award deriv | 2024-01-24 | 2024-02-07 | 50,000 | — | $0 | 50,000 | SEC↗ |
| Schwartz Elissa J. | Director | A Award deriv | 2024-01-24 | 2024-02-07 | 50,000 | — | $0 | 50,000 | SEC↗ |
| Uihlein Richard E | Director, 10% Owner | A Award deriv | 2024-01-24 | 2024-02-07 | 50,000 | — | $0 | 50,000 | SEC↗ |
| Zordani Richard A. Jr. | Director | A Award deriv | 2024-01-24 | 2024-02-07 | 50,000 | — | $0 | 50,000 | SEC↗ |
| Uihlein Richard E | Director, 10% Owner | A Award | 2024-01-24 | 2024-02-07 | 23,256 | $1.72 | $40.0K | 10,268,751 | SEC↗ |
| ELDRED KARY | Director | P Buy | 2024-01-16 | 2024-07-23 | 400 | $2.39 | $956 | 49,713 | SEC↗ |
| ELDRED KARY | Director | P Buy | 2024-01-16 | 2024-01-16 | 500 | $1.79 | $895 | 49,313 | SEC↗ |
| LEWIS JOEL | President and CEO | A Award | 2023-12-29 | 2024-01-02 | 11,606 | $1.66 | $19.3K | 1,042,300 | SEC↗ |
| LEWIS JOEL | President and CEO | A Award | 2023-12-15 | 2023-12-18 | 12,042 | $1.60 | $19.3K | 1,030,694 | SEC↗ |